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The limitations of the traditional research paper are well known and widely discussed; however, rather than seeking
solutions to the problems created by this model of publication, it is time to do away with a print era anachronism
and design a new model of publication, with modern technology embedded at its heart. Instead of the current
system with multiple publications, across multiple journals, publication could move towards a single, evolving
document that begins with trial registration and then extends to include the full protocol and results as they
become available, underpinned by the raw clinical data and all code used to obtain the result. This model would
lead to research being evaluated prospectively, based on its hypothesis and methodology as stated in the study
protocol, and move away from considering serendipitous results to be synonymous with quality, while also
presenting readers with the opportunity to reliably evaluate bias or selective reporting in the published literature.Background
When the Royal Society first advocated the transparent
and open exchange of ideas backed by experimental evi-
dence, the Society was widely ridiculed. At the time, the
concept of openly sharing your work in a research article
was highly controversial. It was not uncommon for new
discoveries to be announced by describing them in pa-
pers coded in anagrams or cyphers [1] - reserving prior-
ity for the discoverer, but largely indecipherable for
anyone not already in on the secret. Both Newton and
Leibniz used this device.
As you might imagine, this led to a number of disputes
over priority, and it seems rather absurd to us today. How-
ever, since the advent of the research article over 300 years
ago, academic publishing has been viewed as a way of
minuting what was done and sharing the results [2].
Three-hundred years is a long time; technology has
seen huge advancements over the last 20 years alone.
The Internet has seismically disrupted the way we both
communicate and find data, displacing traditional infor-
mation delivery and becoming an integral part of life for
millions. The increased availability of information has
led to calls for greater transparency in research - for a
clear, detailed record of exactly what was done, and how,
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‘minutes’. Print era anachronisms persist through the
continuation of page and word limits and the release of
discrete issues, as if all articles remain subject to print-
only production constraints. Indeed, it was only recently
that certain top journals elected to remove the word
limits on their methods sections [3]. It brings to mind
Fermat’s aside to his infamous last theorem written in
Artimetica in 1637, claiming that the proof for what he
stated was ‘too large to fit in the margin’ [4].
Where is the value in the research article?
Research only has value if the methods used are appro-
priate and it is reproducible [5]. However, in modern
biomedical research, the majority of published research
claims may in fact be impossible to reproduce [6-8].
Many reported results are later refuted, and controversy
is seen across the entire range of research designs, from
randomised controlled trials (RCTs) to traditional epi-
demiological studies [9-11]. Even for studies following
‘gold standard’ reporting and open data policies, re-
searchers face difficulties in replicating them [12].
One possible explanation for this, as hypothesized by
Ioannidis et al., is that controversial data are attractive
to investigators and editors, making contradictory results
more likely to be published than confirmatory ones
[7,13]. However, reviews of published trials consistently
show that, even for those articles that are published, keyis is an Open Access article distributed under the terms of the Creative
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growing evidence that space pressures influence the way
that researchers choose to write up their studies, with a
bias in favour of selecting those outcomes and analyses
that are statistically significant [15,16].
It is concerns like these that led to widespread calls for
registering trials [17,18], pre-specifying the research out-
comes and methods. Similarly, reporting guidelines were
created to outline the minimum information required
for a full and complete report, with evidence that the
adoption of reporting guidelines, such as the CONSORT
Statement, has led to improved reporting [19]. Journals
like Trials also encourage prospective publication of
study protocols, which had rarely been possible in
paper-based journals [20,21]; publication of study proto-
cols allows for more detailed discussion of methodo-
logical issues, which can be referenced when reporting
the main trial results [22].
However, researchers need access to all of the relevant
information, to reliably evaluate bias or selective report-
ing in clinical trials. As any systematic reviewer can tell
you, identifying all publications related to a single clin-
ical trial can be a Sisyphean task. Indeed, there are initia-
tives in the works to assist with this effort [23], but
regardless of the success of these initiatives, this simply
serves to highlight the absurdity of having separate
‘protocol’ papers and ‘results’ papers. These are all solu-
tions to a problem that we ourselves have created.
Indeed in 1963, Peter Medawar asked whether the sci-
entific paper itself was a fraud. He maintained that the re-
search article was a ‘travesty […] which editors themselves
often insist upon’, insisting that research articles give ‘a to-
tally misleading narrative of the processes of thought that
go into the making of scientific discoveries’. A paper’s
fraud, Medawar argued, lay mainly in its form [24].
Main text
A ‘living’ document
It is time to ask ourselves whether the research article it-
self has now become an anachronism. In contrast to an
article of the print era, an article that has been published
online is not a sealed black box. It can be updated,
amended, extended and indeed directly linked to other
articles and data.
So why do we with persist with this paradigm whereby
each new ‘stage’ in the research cycle results in a separ-
ate publication? It is time for the research article to
move beyond the now-obsolete print model and truly
embrace the freedom that online publication gives us,
moving towards living documents, with a single article
for a single piece of research.
It is a powerful concept. Currently, a single clinical
trial can result in a study protocol and traditional results
paper (or papers), as well as commentaries, secondaryanalyses and, eventually, systematic reviews, among others
[25]. Instead of multiple publications, across multiple jour-
nals, with associated different publishing formats, re-
searchers could register our intention to perform a clinical
trial, detailing the standard 20-items that are currently re-
quired [26]. This could then be extended to the full study
protocol, building on the skeleton that was provided on
registration. Once they have completed the study, they
can then update the document to include the results and
analyses performed, without having to rewrite the
methods and risk self-plagiarism (Figure 1).
While the article would evolve over time, substantive
additions to the article that were judged to impact the sci-
entific validity of the literature would require peer review,
as shown in Figure 1. In these cases, the article could be
frozen into a discrete version, with the reviewer reports
associated with it. This model is already used by journals
that operate on a post-publication peer review process,
such as F1000Research and ScienceOpen [27,28]. Citations
to the document would then be required to include the
access date, which would uniquely identify the version of
the article referred to.
Creation of a living document that could be updated
as required, would allow researchers to capture the in-
formation in real time, allowing for simpler concurrent
research projects and facilitating reporting, as the au-
thors would only need to focus on a specific section at
any one time, rather than attempt to identify and follow
all the relevant reporting guidelines for the study from
over two hundred [29], when finally writing it up.
This concept of an evolving document is already dem-
onstrated for systematic reviews by the Living Reviews
series of open access journals, which allow the authors to
regularly update their articles to incorporate the latest de-
velopments in the field [30]; however, it has not been ap-
plied to primary research. Extending this concept to
primary research could cause the article to become un-
wieldy under the traditional IMRAD headings, particularly
for large clinical trials with an associated large number of
analyses; however, this is already the case for traditional
results papers. These concerns have led to journals requir-
ing core statistical methods to be included in the figure
captions of presented results, as well as innovative naviga-
tion tools to allow readers to view the research methods
and analyses simultaneously, for example, eLife Lens [31].
Reproducibility also requires the ability to manipulate
and re-analyse data; therefore, as stated by Claerbout, in
addition to any summary results included to support the
written interpretation, the document should link to the
raw clinical data and all code used to obtain the result
[32]. An immense amount of work has gone into the
creation of reproducible research platforms and the con-
cept of ‘literate programming’. This has led to the devel-
opment of a whole programming format, SWeave, which
Figure 1 Workflow for a living document of a randomized controlled trial.
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grated into LaTeX documents, which can be updated
automatically if data or analyses change [33]. Similarly,
Kauppinen et al. established and defined Linked Open
Science, an approach to interconnect scientific assets to
enable transparent, reproducible and transdisciplinary
research [34].
The dramatic decrease in data storage costs [35] and
emergence of virtual environments, such as Arvados
[36], make it possible to enable reproducibility of data
analysis with versioned scripts and tools. Trialists can
deposit the data, tools and scripts they used to analyse
the data, allowing readers to see how robust the visuali-
sations and statistics embedded in the paper are.
Limitations
Underpinning the results and interpretations with the
original data and analyses tools has obvious benefits for
conducting meta-analyses and systematic reviews, as
well as for reproducibility of research. Similarly, creation
of an evolving document for a single research projectwould make evaluation of selective reporting of both
analyses and outcomes straightforward, as all the neces-
sary information and methods would be reported in the
same place. However, there are limitations compared
with the existing publication paradigm. As the article is
able to continuously evolve, there is no permanent ‘ver-
sion of record’; therefore, the articles would need on-
going curation, which could cause issues in the event of
a journal closure. As stated by Barnes in the Science
Code Manifesto, ‘Source code must remain available,
linked to related materials, for the useful lifetime of the
publication’ [37]. While a discrete version could be cre-
ated in such instances, it would prevent further updating
of the article, which could lead to the literature being
incomplete.
Furthermore, by encouraging and facilitating repro-
duction, this raises the issue of how to combine ori-
ginal research articles with follow-up replication or
analyses by a different group of authors. Including these
follow-up studies in the original living document could
cause issues with accreditation; however, it could also help
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of research, leading to large research consortia, as cur-
rently seen in physics and genetics. An alternative to
this would be to adapt the existing ‘update’ article
types, creating a separate citation, but accessed in tan-
dem to the original article.
A continuously-evolving document would also under-
mine existing methods of evaluating the impact of a
piece of work, particularly metrics like the Impact Factor
or any article- or journal-level metric that relies on the
date of publication. As study protocols are seldom cited,
a living document is unlikely to be cited regularly until
the article has been expanded to include the results and
interpretation; however, this means that citations to the
article could come a number of years after original pub-
lication and, therefore, would not be included in the Im-
pact Factor calculations. However, this could also prove
an advantage, as implementation of living documents, as
described above, would require a journal to commit to
publishing the results of a piece of research based on the
methodological quality of the protocol, regardless of out-
come or significance of findings, or considered level of
interest. This could help to move away from a results
focus to considerations of the question asked and the
processes used, when evaluating scientific validity.
Current technology means that this form of publica-
tion is theoretically possible already. However, contem-
porary cultural attitudes and workflows, within both
publishing and academia, along with research conduct
and evaluation, present barriers to its implementation.
Evaluating research prospectively, based on its hypoth-
esis and methodology as stated in the study protocol,
and then continuously updating the article as results and
data become available, moves us past considering seren-
dipitous results as being synonymous with quality, while
also giving us the opportunity to reliably evaluate bias or
selective reporting in the published literature.Conclusion
The current incarnation of the research article has per-
sisted for over 300 years; however, evolving technology
makes it, not simply anachronistic, but effectively fraudu-
lent. While cultural attitudes and establishments remain a
large hurdle, both within the publishing and academic
communities, the ongoing drive towards transparency and
reproducibility make it no longer acceptable to continue
to perpetuate a centuries-old absurdity.
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